D. Oyon

发表

The Balanced Scorecard: a Necessary Good or an Unnecessary Evil

Didier P. Hostettler, Stella Mooraj, D. Oyon, 1999 .

Collected insights from the field of sport

D. Oyon, Geert Hendriks, K. Gilbert, 2014 .

What to do against disruptive business models: when and how to play two games at once

Daniel Oyon, Constantinos C. Markides, C. Markides, 2010 .

Accounting and Control, Entrepreneurship and Innovation: Venturing into New Research Opportunities

Antonio Davila, George Foster, Daniel Oyon, 2009 .

Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures

K. Zieniewicz, M. Krawczyk, B. Sangro, 2021, Gut.

Pilot Multi-Omic Analysis of Human Bile from Benign and Malignant Biliary Strictures: A Machine-Learning Approach

B. Sangro, A. Pineda-Lucena, F. Corrales, 2020, Cancers.

Hemostatic spray powder TC-325 for GI bleeding in a nationwide study: survival and predictors of failure via competing risks analysis.

G. Pagano, E. Martínez-Moneo, E. Vazquez-Sequeiros, 2019, Gastrointestinal endoscopy.

Principles of surgery for malignant astrocytomas.

A. Parsa, D. Oyon, O. Bloch, 2014, Seminars in oncology.

Environmental management accounting systems: A review of the evidence and propositions for future research

Giovanni Battista Derchi, Michael Burkert, Daniel Oyon, 2013 .

Blockholder Heterogeneity and Audit Fees: Does Private Information Matter?

C. Lesage, D. Oyon, Chiraz Ben Ali, 2022, Accounting in Europe.

[The Balanced Scorecard: quality management in aide associations/foundations and home care services].

D. Oyon, J. Charbon, D. Oyón, 2001, Revue medicale de la Suisse romande.

Using management control systems to support agility

C. Markides, D. Oyon, M. Schnegg, 2018 .

The Information Content of Common Stock Repurchases: An Empirical Study1

C. Ittner, C. Markides, D. Oyon, 1994 .

An Unusual Case of Gordonia sputi Cerebral Infection

M. Tate, D. Oyon, M. Bolon, 2021, Infectious Diseases in Clinical Practice.

Overview: Management Control Systems as a Source for Creating Value

Stella Mooraj, D. Oyon, 1999 .

The immune checkpoint protein PD-L1 induces and maintains regulatory T cells in glioblastoma

G. Kaur, D. Oyon, Leonel Ampie, 2018, Oncoimmunology.

Immunomonitoring in glioma immunotherapy: current status and future perspectives

K. Kesavabhotla, A. Parsa, D. Oyon, 2016, Journal of Neuro-Oncology.

Bladder cancers arise from distinct urothelial sub-populations

C. Cordon-Cardo, M. Mansukhani, Xue-Ru Wu, 2014, Nature Cell Biology.

Vaccine Therapies in Malignant Glioma

A. Parsa, D. Oyon, O. Bloch, 2014, Current Neurology and Neuroscience Reports.

Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth

C. James, C. Horbinski, G. Kaur, 2019, Clinical Cancer Research.

Robotic Tissue Manipulation and Resection in Spine Surgery.

J. Wolinsky, D. Oyon, S. J. Trybula, 2020, Neurosurgery clinics of North America.

Green incentives for environmental goals

Antonio Dávila, D. Oyon, G. Derchi, 2023, Management Accounting Research.

Relating alternative forms of contingency fit to the appropriate methods to test them

Antonio Davila, Michael Burkert, Daniel Oyon, 2014 .

Shareholder Protection: The Role of Multiple Large Shareholders

Antonio Dávila, Michael Burkert, D. Oyon, 2016, SSRN Electronic Journal.

Cross-paradigm collaboration and the advancement of management accounting knowledge

Tony Davila, D. Oyon, D. Oyón, 2008 .

Risk Ownership, ERM Practices, and the Role of the Finance Function

Christopher D. Ittner, C. Ittner, D. Oyon, 2020, Journal of Management Accounting Research.

The Internal Organization of Enterprise Risk Management

C. Ittner, D. Oyon, 2014 .

Performance consequences of balanced scorecard adoptions: Claim for large-scale evidence and propositions for future research

Antonio Davila, Michael Burkert, Daniel Oyon, 2010 .

Does the Balanced Scorecard Add Value? Empirical Evidence on its Effect on Performance

Daniel Oyon, Fabien De Geuser, Stella Mooraj, 2009 .